The global Infectious disease diagnostics market is expected to grow during the forecast period owing to the increasing prevalence of various infectious diseases such as malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs, and diarrheal diseases. The other vital drivers of this market are the growing demand for rapid diagnostic techniques over the current techniques due to the long turnaround time and supportive government funding. The various methods used for diagnosis are microbiological techniques, intensive care medicine, and clinical laboratory techniques
The infectious disease diagnostics market is segmented on the basis of product, technology, and application. On the basis of technology, the market is bifurcated into, molecular and traditional diagnostic techniques. Further, the molecular diagnostic technique is classified into INAAT (Isothermal Nucleic Acid Amplification Test), Polymerase Chain Reaction (PCR), NGS & DNA sequencing, hybridization, and microarrays. The traditional diagnostic technique is classified into biochemical characterization, microscopy, and immunodiagnostics. Among these PCR and INAAT holds the larger market share. PCR is a reaction process through which multiple images of DNA is generated from a particular DNA sequence. On the basis of application, the infectious disease diagnostic market is bifurcated into, Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA). Among these TB holds the larger market share. TB is generally caused by mycobacterium tuberculosis. On the basis of product, the market is classified into consumables (assays and reagents), software & services, and instruments & analyzers. Among these consumables held the largest market share as of 2013.
Geographically, the infectious disease diagnostics market is studied with respect to four regions such as North America, Europe, Asia Pacific, and RoW. Among these North America is dominating the whole region followed by Europe due to the presence of a large number of the patient population, a large amount of investment in this sector and healthcare infrastructure, and various government initiatives. Asia Pacific market is expected to have a lucrative growth rate due to the high prevalence of infectious diseases, and patient awareness.
The major market players in the infectious disease diagnostics market are Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation and Johnson and Johnson.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor.